[{"id":"665a24f0-30ae-47ae-bd4a-55761e74693b","acronym":"","url":"https://clinicaltrials.gov/study/NCT02948075","created_at":"2021-01-18T14:28:35.503Z","updated_at":"2024-07-02T16:37:09.434Z","phase":"Phase 2","brief_title":"Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy","source_id_and_acronym":"NCT02948075","lead_sponsor":"NewVac LLC","biomarkers":" BRCA1 • ERCC1 • CDH1","pipe":" | ","alterations":" BRCA1 expression • CDH1 expression • ERCC1 expression","tags":["BRCA1 • ERCC1 • CDH1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA1 expression • CDH1 expression • ERCC1 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel • quisinostat (JNJ 26481585)"],"overall_status":"Completed","enrollment":" Enrollment 31","initiation":"Initiation: 09/01/2015","start_date":" 09/01/2015","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 06/16/2017","study_completion_date":" 06/16/2017","last_update_posted":"2018-06-27"}]